What is Transmural Systems?
Transmural Systems is a privately held medical device company dedicated to advancing transcatheter therapies for cardiovascular diseases. The company's core mission involves simplifying complex healthcare challenges through innovative electrosurgical structural heart therapies. Leveraging a multi-disciplined team with extensive industry experience, Transmural Systems is positioned to reshape patient care paradigms. Their solutions are designed for healthcare providers and patients requiring sophisticated cardiovascular treatments.
How much funding has Transmural Systems raised?
Transmural Systems has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Transmural Systems
PPP
Public-Private Partnership
What's next for Transmural Systems?
The substantial late-stage funding indicates Transmural Systems is poised for significant growth and market penetration. This capital injection will likely fuel further research and development, scale manufacturing capabilities, and expand commercialization efforts for their transcatheter therapies. The strategic investment suggests confidence from backers in the company's ability to capture a substantial share of the cardiovascular device market and address unmet clinical needs.
See full Transmural Systems company page
